HIV medication worldwide sales by type 2008-2012

This statistic depicts the differentiation in worldwide sales for human immunodeficiency virus (HIV) medication from 2008 to 2012, by drug type. In 2010, the fixed-dose combination drugs accounted for 56% and plain active ingredient drugs accounted for 44% of HIV medication sold. In 2013, about 34 million people around the world were suffering from HIV but due to advances in medication, it is considered a manageable chronic condition. Although, antiretroviral therapy has made living with HIV much more manageable, there are many in the developing world that still have no access to sufficient medical treatment. HIV antiviral volume is decreasing as fixed-dose combination therapy becomes more prominent.

本统计数据描绘了2008年至2012年全球人类免疫缺陷病毒（HIV）药物治疗销售情况的差异，按药物类型分类。2010年，固定剂量复合药物占HIV药物销售的56%，而普通活性成分药物占44%。至2013年，全球约有3400万人感染HIV，但由于药物治疗方面的进步，它被视为一种可控的慢性疾病。尽管抗逆转录病毒疗法使HIV患者的生活管理变得更加容易，但在发展中国家仍有很多人无法获得充足的医疗治疗。随着固定剂量复合疗法的日益突出，HIV抗病毒药物的销售量正在下降。